The following gating schemes were used to define CD11c+ MHC II+, CD11b+ MHC II+ cells, CD8+ T cells, CD4+ T cells and Treg cells in (a) draining lymph nodes and mesenteric lymph nodes and (b) tumor-infiltrating immune cells. (c) Gating strategy to examine OT-I cells stimulated by OVA-loaded BMDCs. (d) Gating strategy used to analyze tumor cells from the mice implanted with MC38 tumor cells expressing GFP. Gating strategies used to sort CD4+ T cells, CD8+ T cells, CD11c+MHC II+ cells and CD11b+ cells from (e) tumor-infiltrating leukocytes and (f) tumor draining lymph nodes.